Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13,986 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip E, Altorki N, Zhou C, Csőszi T, Vynnychenko I, Goloborodko O, Luft A, Akopov A, Martinez-Marti A, Kenmotsu H, Chen YM, Chella A, Sugawara S, Voong D, Wu F, Yi J, Deng Y, McCleland M, Bennett E, Gitlitz B, Wakelee H; IMpower010 Investigators. Felip E, et al. Among authors: wu f. Lancet. 2021 Oct 9;398(10308):1344-1357. doi: 10.1016/S0140-6736(21)02098-5. Epub 2021 Sep 20. Lancet. 2021. PMID: 34555333 Clinical Trial.
Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
Huang W, Liu J, Zeng Y, Wu F, Li N, Chen K, Hong Y, Wang L, Zhen H, Lin L. Huang W, et al. Among authors: wu f. Cancer Chemother Pharmacol. 2018 Oct;82(4):607-613. doi: 10.1007/s00280-018-3639-z. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043207 Clinical Trial.
Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study.
Huang W, Wang C, Wang L, Shen Y, Chen Q, Huang Z, Liu J, Lin X, Wu F, Chen X, Li N, Hong Y, Chen M, Li J, Huang C. Huang W, et al. Among authors: wu f. Front Cell Dev Biol. 2024 Feb 22;12:1313610. doi: 10.3389/fcell.2024.1313610. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38481526 Free PMC article.
The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experience.
Wu F, Chen M, Wang L, Li N, Wu X, Chen X, Hong Y, Li C, Lin L, Chen K, Huang W, Liu J. Wu F, et al. Among authors: wu x. Curr Cancer Drug Targets. 2023 Oct 24. doi: 10.2174/0115680096248592231016065117. Online ahead of print. Curr Cancer Drug Targets. 2023. PMID: 37916639
13,986 results
You have reached the last available page of results. Please see the User Guide for more information.